Sangamo BioSciences | SGMO - Trade Creditors


Sangamo BioSciences reported $10.74M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 843K 34K Sep/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Bayer EUR 7.08B 700M Dec/2025
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.46B 99M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.93B 927M Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025